POLSINELLI PC for TEVA PHARMACEUTICALS USA, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act Coronavirus stimulus legislation Review of Administration drug pricing and telehealth policies H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act
Foreign entity interest: Teva Pharmaceutical Industries LTD, as the indirect parent of TEVA Pharmaceuticals USA INC, has an interest in the issues listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT DALEY | — |
| SYLVIA STANOJEV KORNEGAY | — |
| TIM PERRIN | — |
| HARRY ANASTASIOS SPORIDIS | — |
| STEVEN STRANNE | — |
| ALAN WHEAT | — |
Pharmacy PHA
S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act Coronavirus stimulus legislation Review of Administration drug pricing and telehealth policies H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act
Foreign entity interest: Teva Pharmaceutical Industries LTD, as the indirect parent of TEVA Pharmaceuticals USA INC, has an interest in the issues listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT DALEY | — |
| SYLVIA STANOJEV KORNEGAY | — |
| TIM PERRIN | — |
| HARRY ANASTASIOS SPORIDIS | — |
| STEVEN STRANNE | — |
| ALAN WHEAT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.